MBX

MBX Biosciences, Inc. Common StockNASDAQHealthcare

$32.99+2.17%ClosedMarket Cap: $1.11B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-01-16	Guggenheim	—	Buy	—
2025-12-19	Stifel	—	Buy	—
2025-11-10	Guggenheim	—	Buy	—
2025-09-24	Mizuho	—	Outperform	—
2025-09-23	Guggenheim	—	Buy	—
2025-09-23	Oppenheimer	—	Outperform	—
2025-04-10	Guggenheim	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-4.22	$0.00	7
Sun Dec 31	$-4.44	$26.5M	8
Mon Dec 31	$-3.09	$131.4M	6
Tue Dec 31	$-1.61	$256.3M	6